Deutsch English Français

Contact

EP0983228

European procedure

Quick help

Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...

News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...

Extract from the Register of European Patents

EP About this file: EP0983228

EP0983228 - PROTEASE INHIBITORS [Right-click to bookmark this link]
Status	The application is deemed to be withdrawn Status updated on 10.09.2004 Database last updated on 20.09.2024
Most recent event Tooltip	10.09.2004	Application deemed to be withdrawn	published on 27.10.2004 [2004/44]
Applicant(s)	For all designated states SMITHKLINE BEECHAM CORPORATION One Franklin Plaza P.O. Box 7929 Philadelphia Pennsylvania 19103 / US
	[N/P]
Former [2000/10]	For all designated states SMITHKLINE BEECHAM CORPORATION One Franklin Plaza P.O. Box 7929 Philadelphia Pennsylvania 19103 / US
Inventor(s)	01 / BONDINELL, William, Edward 1512 Franklin Lane Wayne, PA 19087 / US
	02 / DesJARLAIS, Renee, Louise 11 Cornwall Circle St. Davids, PA 19087 / US
	03 / VEBER, Daniel, Frank 290 Batleson Road Ambler, PA 19002 / US
	04 / YAMASHITA, Dennis, Shinji 703 Edgewood Road King of Prussia, PA 19406 / US
	[2000/10]
Representative(s)	Rutter, Keith, et al GlaxoSmithKline Corporate Intellectual Property (CN9.25.1) 980 Great West Road Brentford, Middlesex TW8 9GS / GB
	[N/P]
Former [2000/10]	Rutter, Keith, Dr., et al SmithKline Beecham plc Corporate Intellectual Property, Two New Horizons Court Brentford, Middlesex TW8 9EP / GB
Application number, filing date	98918878.4	30.04.1998
	[2000/10]
	WO1998US08764
Priority number, date	US19970046862P	08.05.1997 Original published format: US 46862 P
	[2000/10]
Filing language	EN
Procedural language	EN
Publication	Type:	A1 Application with search report
	No.:	WO9850342
	Date:	12.11.1998
	Language:	EN
	[1998/45]
	Type:	A1 Application with search report
	No.:	EP0983228
	Date:	08.03.2000
	Language:	EN
	The application published by WIPO in one of the EPO official languages on 12.11.1998 takes the place of the publication of the European patent application.
	[2000/10]
Search report(s)	International search report - published on:	US	12.11.1998
	(Supplementary) European search report - dispatched on:	EP	20.06.2002
Classification	IPC:	C07C233/00	[2000/10]
	CPC:	C07D213/30 (EP,US); C07C233/00 (KR); A61P1/02 (EP); A61P19/02 (EP); A61P19/04 (EP); A61P19/10 (EP); (+) A61P29/00 (EP); A61P43/00 (EP); C07C233/40 (EP,US); C07C271/22 (EP,US); C07C311/18 (EP,US); C07D211/62 (EP,US); C07D213/56 (EP,US); C07D213/71 (EP,US); C07D213/81 (EP,US); C07D215/36 (EP,US); C07D215/48 (EP,US); C07D233/64 (EP,US); C07D257/04 (EP,US); C07D401/12 (EP,US); C07C2601/14 (EP,US) (-)
Designated contracting states	AT, BE, CH, CY, DE, DK, ES, FI, FR, GB, GR, IE, IT, LI, LU, MC, NL, PT, SE [2000/10]
Extension states	SI	17.11.1999
Title	German:	PROTEASEINHIBITOREN	[2000/10]
	English:	PROTEASE INHIBITORS	[2000/10]
	French:	INHIBITEURS DE PROTEASES	[2000/10]
Entry into regional phase	17.11.1999	National basic fee paid
	17.11.1999	Search fee paid
	17.11.1999	Designation fee(s) paid
	17.11.1999	Examination fee paid
Examination procedure	04.12.1998	Request for preliminary examination filed International Preliminary Examining Authority: US
	17.11.1999	Examination requested [2000/10]
	09.12.2003	Despatch of a communication from the examining division (Time limit: M04)
	20.04.2004	Application deemed to be withdrawn, date of legal effect [2004/44]
	27.05.2004	Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time [2004/44]
Request for further processing for:	06.01.2003	Request for further processing filed
	06.01.2003	Full payment received (date of receipt of payment) Request granted
	03.02.2003	Decision despatched
Fees paid	Renewal fee
	07.04.2000	Renewal fee patent year 03
	09.04.2001	Renewal fee patent year 04
	08.04.2002	Renewal fee patent year 05
	07.04.2003	Renewal fee patent year 06
	06.04.2004	Renewal fee patent year 07
Opt-out from the exclusive Tooltip competence of the Unified Patent Court	See the Register of the Unified Patent Court for opt-out data
	Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:	Search	[X]EP0181071 (SQUIBB & SONS INC [US]) [X] 1,4,6,17,39,42,44 * examples 1-23; claims 1,15 *;
		[X]DE3542567 (SQUIBB & SONS INC [US]) [X] 1,4,6,17,39,42,44 * examples 1-27; claims 1,22 *;
		[X]EP0190891 (KISSEI PHARMACEUTICAL [JP]) [X] 39 * abstract *;
		[X]US4640911 (BASCHANG GERHARD [CH], et al) [X] 39,41 * column A; examples 1,2,9,15-19,21,24,25,29-31 *;
		[X]EP0223437 (SQUIBB & SONS INC [US]) [X] 39,42-44 * examples 1-36; claims 1,11 *;
		[X]DE3643977 (SQUIBB & SONS INC [US]) [X] 39,43,44 * examples 1-29; claims 1,21 *;
		[X]DE3800591 (SANDOZ AG [DE]) [X] 39 * abstract *;
		[X]WO9009191 (SCHRAMM WOLFGANG [DE], et al) [X] 39,43 * abstract ** page 21, line 10 - line 23 *;
		[DX]EP0525420 (MITSUBISHI CHEM IND [JP]) [DX] 1,4,17,46,47,49,50 * abstract * * page 4, line 12 - line 18 * * tab.1: cpd.197-199,461-484 * * examples 190,191 *;
		[DA]EP0603873 (MITSUBISHI CHEM IND [JP]) [DA] 1,17 * abstract * * page 4, line 13 - line 19 * * tab.1: cpd. 359,360,381-383,391,417 *;
		[X]WO9524385 (VERTEX PHARMA [US], et al) [X] 39,44,45 * abstract * * tab.1: cpd.1027 *;
		[X]WO9628465 (SEARLE & CO [US], et al) [X] 39,42 * abstract * * tables 3A-E,4A-D,5A-D,7A-F,8A-F,9A-F *;
		[X]US5559256 (GORDON ERIC M [US], et al) [X] 39,42 * column A; claim 1 * * examples 38,41,53-56,62,66-73,77-105,111-121,125,133,134 * * examples 141,171,202-205,211,212,219-225,234,243-250 * * examples 254-265,280-288,297,311,315,320-328,340-342,351 * * examples 352,359,373,374,383 *;
		[X]US5585397 (TUNG ROGER D [US]) [X] 39,42 * column A; claim 1; tables I-V *;
		[PX]WO9716433 (SMITHKLINE BEECHAM CORP [US], et al) [PX] 1,3-14,17,39,41-55 * claims 1,20,26,37,63-72 * * examples 37-61,210-291 *;
		[X] - MOREE ET AL, "Exploitation of Subtilisin BPN' as Catalyst for the Synthesis o Peptides Containing Noncoded Amino Acids, Peptide Mimetics and Peptide Conjugates", JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, AMERICAN CHEMICAL SOCIETY, WASHINGTON, DC, US, (19970430), vol. 119, no. 17, ISSN 0002-7863, pages 3942 - 3947, XP002107597 [X] 39,41,45 * abstract * DOI: http://dx.doi.org/10.1021/ja964399w
		[X] - STEPINSKI J ET AL, "NEW DIMERIC TETRAPEPTIDE ENKEPHALIN ANALOGUES HYDROPHILIC SPACER LENGTH AND CONFIGURATION AFFECTS POTENCY AND RECEPTOR SELECTIVITY", ZEITSCHRIFT FUR NATURFORSCHUNG, TEIL B: ANORGANISCHE CHEMIE, ORGANISCHE CHEMIE, VERLAG DER ZEITSCHRIFT FUR NATURFORSCHUNG. TUBINGEN, DE, (1994), vol. 49, no. 3, ISSN 0932-0776, pages 407 - 411, XP001053394 [X] 39,41,43,44 * abstract *
		[X] - JACOBSON A R ET AL, "MINIMUM-STRUCTURE ENKEPHALIN ANALOGUES INCORPORATING L-TYROSINE, D(OR L)-PHENYLALANINE, AND A DIAMINE SPACER", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, (1989), vol. 32, ISSN 0022-2623, pages 1708 - 1717, XP001053393 [X] 39,41,43,44 * abstract * * scheme 4: cpd.7a,b * DOI: http://dx.doi.org/10.1021/jm00128a007
		[X] - NATARAJAN S ET AL, "TRIPEPTIDE AMINOALCOHOLS: A NEW CLASS OF HUMAN RENIN INHIBITORS", PEPTIDES: CHEMISTRY AND BIOLOGY, XX, XX, (1987), pages 131 - 133, XP008000424 [X] 39 * the whole document *
		[X] - LULY J R ET AL, "NEW INHIBITORS OF HUMAN RENIN THAT CONTAIN NOVEL LEU-VAL REPLACEMENTS", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, (1987), vol. 30, no. 9, ISSN 0022-2623, pages 1609 - 1616, XP001053395 [X] 39 * abstract * * tab.II: cpd.34,37,47 * DOI: http://dx.doi.org/10.1021/jm00392a015
		[X] - ROSENBERG S H ET AL, "NOVEL RENIN INHIBITORS CONTAINING ANALOGUES OF STATINE RETRO-INVERTED AT THE C-TERMIN: SPECIFICITY AT THE P2 HISTIDINE SITE1,2", JOURNAL OF MEDICINAL CHEMISTRY, AMERICAN CHEMICAL SOCIETY. WASHINGTON, US, (19870701), vol. 30, no. 7, ISSN 0022-2623, pages 1224 - 1228, XP002027217 [X] 39 * page 1224 - page 1225 * * tab.I: cpd.16-18,30 * DOI: http://dx.doi.org/10.1021/jm00390a018
		[X] - DANN, J.G. ET AL., BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, (1986), vol. 134, no. 1, pages 71 - 77, XP001040319 [X] 39,42,43 * page 71 - page 74; table 1 * DOI: http://dx.doi.org/10.1016/0006-291X(86)90528-0
	International search	[A]US4638010 (WELLER III HAROLD N [US], et al);
		[A]US4749792 (NATARAJAN SESHA I [US], et al)

The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.

Legal notice
Terms of use
24.2.25; 35p